Stryker Corp., of Kalamazoo, Mich., reported that the U.S. FDA has given the green light to the Neuroform Atlas stent system, which previously was approved under a humanitarian device exemption (HDE). (See BioWorld MedTech, Nov. 10, 2017.) It is intended for wide-neck, intracranial aneurysms in conjunction with embolic detachable coils.

Palo Alto, Calif.-based startup Symphonyrm reported picking up $10 million in series A financing, led by Adam Street Partners, to help accelerate its growing investment in its artificial intelligence (AI) algorithms and consumer relationship management platform.